Research Overview
NL GLP-2 is a dual-pathway research peptide studied for its activity at both GIP and GLP-1 receptors. Research has focused on metabolic signaling, appetite and energy-intake regulation, glucose-dependent insulin signaling, body-weight regulation, and body-composition pathways.
Quality & Testing
Novanix Labs evaluates compounds for purity, mass, and identity as part of our quality-assurance process. Analytical testing is used to verify compound identity, assess chemical purity, and confirm the amount of material present. Testing documentation is maintained as part of our commitment to consistency, transparency, and research standards.
Additional Research Information
NL GLP-2 activates both GIP and GLP-1 receptors, two incretin pathways involved in metabolic and energy regulation. Research has examined this dual-receptor activity in relation to appetite and caloric intake, glucose-dependent insulin secretion, glucagon regulation, insulin sensitivity, energy balance, and body-weight regulation. Human clinical research involving this dual-pathway mechanism has demonstrated significant effects on glycemic regulation and body weight, making it an important area of metabolic and body-composition research.